Sars-Cov-2 and risk of antiviral drug resistance

被引：0
|
作者：
Antonio Vitiello
机构：
[1] Clinical Pharmacologist,
[2] Pharmaceutical Department Usl Umbria 1,undefined
来源：
Irish Journal of Medical Science (1971 -) | 2022年 / 191卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2367 / 2368
页数：1
相关论文
共 50 条
  • [1] Sars-Cov-2 and risk of antiviral drug resistance
    Vitiello, Antonio
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (05) : 2367 - 2368
  • [2] Emerging SARS-CoV-2 Resistance After Antiviral Treatment
    Tamura, Trevor J.
    Choudhary, Manish C.
    Deo, Rinki
    Yousuf, Fizah
    Gomez, Anadela Navarrete
    Edelstein, Gregory E.
    Boucau, Julie
    Glover, Owen T.
    Barry, Mamadou
    Gilbert, Rebecca F.
    Reynolds, Zahra
    Li, Yijia
    Tien, Dessie
    Vyas, Tammy D.
    Passell, Eliza
    Su, Karry
    Drapkin, Sarah
    Abar, Emory G.
    Kawano, Yumeko
    Sparks, Jeffrey A.
    Wallace, Zachary S.
    Vyas, Jatin M.
    Shafer, Robert W.
    Siedner, Mark J.
    Barczak, Amy K.
    Lemieux, Jacob E.
    Li, Jonathan Z.
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [3] A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance
    Kumar, Manish
    Mazumder, Payal
    Mohapatra, Sanjeeb
    Thakur, Alok Kumar
    Dhangar, Kiran
    Taki, Kaling
    Mukherjee, Santanu
    Patel, Arbind Kumar
    Bhattacharya, Prosun
    Mohapatra, Pranab
    Rinklebe, Joerg
    Kitajima, Masaaki
    Hai, Faisal I.
    Khursheed, Anwar
    Furumai, Hiroaki
    Sonne, Christian
    Kuroda, Keisuke
    JOURNAL OF HAZARDOUS MATERIALS, 2021, 405
  • [4] SARS-CoV-2 Antiviral Therapy
    Tao, Kaiming
    Tzou, Philip L.
    Nouhin, Janin
    Bonilla, Hector
    Jagannathan, Prasanna
    Shafer, Robert W.
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (04)
  • [5] SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
    Elshabrawy, Hatem A.
    VACCINES, 2020, 8 (02) : 1 - 33
  • [6] Evaluation of the therapeutic action of original antiviral drug in SARS-CoV-2
    Melkonian, Arthur K.
    Hakobyan, Gagik V.
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2024, 71 (05) : 1057 - 1069
  • [7] Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
    Sarkar, Arighna
    Mandal, Kalyaneswar
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (44) : 23492 - 23494
  • [8] Sierra SARS-CoV-2 sequence and antiviral resistance analysis program
    Tzou, Philip L.
    Tao, Kaiming
    Sahoo, Malaya K.
    Pond, Sergei L. Kosakovsky
    Pinsky, Benjamin A.
    Shafer, Robert W.
    JOURNAL OF CLINICAL VIROLOGY, 2022, 157
  • [9] Antiviral drugs against SARS-CoV-2
    Aiello, Tommaso Francesco
    Garcia-Vidal, Carolina
    Soriano, Alex
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 10 - 15
  • [10] Research Progress of Antiviral Drug Targeting the Main Protease of SARS-CoV-2
    Wang, Chunxia
    Hu, Xiaodong
    Xu, Bin
    Cao, Chunyang
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (07) : 1974 - 1999
12345